<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "5: These ", fill: "#9678b6"},
{source: "5: These ", target: "5: guarantees", fill: "#9678b6"},
{source: "5: guarantees", target: "5: future performance", fill: "#9678b6"},
{source: "5: future performance", target: "5: risks uncertainties", fill: "#9678b6"},
{source: "5: risks uncertainties", target: "5: assumptions", fill: "#9678b6"},
{source: "5: These ", target: "9: significant", fill: "#893f45"},
{source: "9: significant", target: "9: health care", fill: "#893f45"},
{source: "9: significant", target: "18: factors may", fill: "#6e7f80"},
{source: "18: factors may", target: "18: increased use", fill: "#6e7f80"},
{source: "18: increased use", target: "18: prescription drugs", fill: "#6e7f80"},
{source: "18: prescription drugs", target: "18: increased cost", fill: "#6e7f80"},
{source: "18: increased cost", target: "18: such services", fill: "#6e7f80"},
{source: "18: such services", target: "18: membership", fill: "#6e7f80"},
{source: "18: membership", target: "18: actual versus", fill: "#6e7f80"},
{source: "18: actual versus", target: "18: cost associated with", fill: "#6e7f80"},
{source: "18: cost associated with", target: "18: new products benefits", fill: "#6e7f80"},
{source: "18: new products benefits", target: "18: Contents ", fill: "#6e7f80"},
{source: "18: Contents ", target: "18: demographic characteristics", fill: "#6e7f80"},
{source: "18: demographic characteristics", target: "18: termination", fill: "#6e7f80"},
{source: "18: termination", target: "18: capitation arrangements", fill: "#6e7f80"},
{source: "18: capitation arrangements", target: "18: reductions", fill: "#6e7f80"},
{source: "18: reductions", target: "18: utilization management functions such as", fill: "#6e7f80"},
{source: "18: utilization management functions such as", target: "18: preauthorization", fill: "#6e7f80"},
{source: "18: preauthorization", target: "18: services concurrent review", fill: "#6e7f80"},
{source: "18: services concurrent review", target: "18: requirements", fill: "#6e7f80"},
{source: "18: requirements", target: "18: physician referrals", fill: "#6e7f80"},
{source: "18: physician referrals", target: "18: pharmacy rebate program with drug", fill: "#6e7f80"},
{source: "18: pharmacy rebate program with drug", target: "18: manufacturers", fill: "#6e7f80"},
{source: "18: manufacturers", target: "18: catastrophes", fill: "#6e7f80"},
{source: "18: catastrophes", target: "18: terrorism public health epidemics", fill: "#6e7f80"},
{source: "18: terrorism public health epidemics", target: "18: severe weather eg", fill: "#6e7f80"},
{source: "18: severe weather eg", target: "18: Hurricane Katrina ", fill: "#6e7f80"},
{source: "18: Hurricane Katrina ", target: "18: introduction", fill: "#6e7f80"},
{source: "18: introduction", target: "18: treatments", fill: "#6e7f80"},
{source: "18: treatments", target: "18: technologies", fill: "#6e7f80"},
{source: "18: technologies", target: "18: government", fill: "#6e7f80"},
{source: "18: government", target: "18: regulatory", fill: "#6e7f80"},
{source: "18: factors may", target: "19: adequately", fill: "#039"},
{source: "19: adequately", target: "19: operations", fill: "#039"},
{source: "19: operations", target: "19: cash flows", fill: "#039"},
{source: "19: adequately", target: "22: competitors", fill: "#00416a"},
{source: "22: competitors", target: "22: health care industry", fill: "#00416a"},
{source: "22: health care industry", target: "22: larger market", fill: "#00416a"},
{source: "22: larger market", target: "22: financial resources than", fill: "#00416a"},
{source: "22: competitors", target: "49: growth may", fill: "#1560bd"},
{source: "49: growth may", target: "49: financial position", fill: "#1560bd"},
{source: "49: financial position", target: "49: operations", fill: "#1560bd"},
{source: "49: operations", target: "49: cash flows", fill: "#1560bd"},
{source: "49: growth may", target: "92: Our Government Segment ", fill: "#007ba7"},
{source: "92: Our Government Segment ", target: "92: Government Segment ", fill: "#007ba7"},
{source: "92: Government Segment ", target: "92: approximately", fill: "#007ba7"},
{source: "92: approximately", target: "92: total premiums", fill: "#007ba7"},
{source: "92: total premiums", target: "92: December ", fill: "#007ba7"},
{source: "92: December ", target: "92: greater percentage", fill: "#007ba7"},
{source: "92: greater percentage", target: "92: for a ASO ", fill: "#007ba7"},
{source: "92: Our Government Segment ", target: "122: subsidiaries", fill: "#0ff"},
{source: "122: subsidiaries", target: "122: cash transfers", fill: "#0ff"},
{source: "122: cash transfers", target: "122: or other Humana Inc ", fill: "#0ff"},
{source: "122: or other Humana Inc ", target: "122: minimum levels", fill: "#0ff"},
{source: "122: minimum levels", target: "122: equity as well as limit investments", fill: "#0ff"},
{source: "122: equity as well as limit investments", target: "122: approved securities", fill: "#0ff"},
{source: "122: subsidiaries", target: "START_HERE", fill: "#0ff"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Health Care Supplies</td>
    </tr>
    <tr>
      <td>Health Care</td>
    </tr>
    <tr>
      <td>Health Care Equipment and Services</td>
    </tr>
    <tr>
      <td>Managed Health Care</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
    <tr>
      <td>Commercial and Professional Services</td>
    </tr>
    <tr>
      <td>Diversified Commercial Services</td>
    </tr>
    <tr>
      <td>Human Resource and Employment Services</td>
    </tr>
    <tr>
      <td>Diversified Financial Services</td>
    </tr>
    <tr>
      <td>Pharmaceuticals Biotechnology and Life Sciences</td>
    </tr>
    <tr>
      <td>Pharmaceuticals</td>
    </tr>
    <tr>
      <td>Insurance Brokers</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Empathize</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Ask for protection</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Reduce routine activity</td>
    </tr>
    <tr>
      <td>Riot</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contract">Contract</a></td>
      <td>A contract is a legally enforceable agreement that creates, defines, and governs mutual rights and obligations among its parties. A contract typically involves the transfer of goods, services, money, or a promise to transfer any of those at a future date.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_figures">Significant figures</a></td>
      <td>Significant figures (also known as the significant digits, precision or resolution) of a number in positional notation are digits in the number that are reliable and necessary to indicate the quantity of something.\nIf a number expressing the result of a measurement (e.g., length, pressure, volume, or mass) has more digits than the number of digits allowed by the measurement resolution, then only as many digits as allowed by the measurement resolution are reliable, and so only these can be significant figures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bit_numbering">Bit numbering</a></td>
      <td>In computing, bit numbering is the convention used to identify the bit positions in a binary number.\n\n\n== Bit significance and indexing ==\n\nIn computing, the least significant bit (LSB) is the bit position in a binary integer representing the binary 1s place of the integer.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Internet">Internet</a></td>
      <td>In finance and economics, interest is payment from a borrower or deposit-taking financial institution to a lender or depositor of an amount above repayment of the principal sum (that is, the amount borrowed), at a particular rate. It is distinct from a fee which the borrower may pay the lender or some third party.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Health_care">Health care</a></td>
      <td>Health care or healthcare is the maintenance or improvement of health via the prevention, diagnosis, treatment, amelioration, or cure of disease, illness, injury, and other physical and mental impairments in people. Health care is delivered by health professionals and allied health fields.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Universal_health_care">Universal health care</a></td>
      <td>Universal health care (also called universal health coverage, universal coverage, or universal care) is a health care system in which all residents of a particular country or region are assured access to health care. It is generally organized around providing either all residents or only those who cannot afford on their own, with either health services or the means to acquire them, with the end goal of improving health outcomes.Universal healthcare does not imply coverage for all cases and for all people – only that all people have access to healthcare when and where needed without financial hardship.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Affordable_Care_Act">Affordable Care Act</a></td>
      <td>The Affordable Care Act (ACA), formally known as the Patient Protection and Affordable Care Act, and colloquially known as Obamacare, is a landmark U.S. federal statute enacted by the 111th United States Congress and signed into law by President Barack Obama on March 23, 2010. Together with the Health Care and Education Reconciliation Act of 2010 amendment, it represents the U.S. healthcare system's most significant regulatory overhaul and expansion of coverage since the enactment of Medicare and Medicaid in 1965.The ACA's major provisions came into force in 2014.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_agency">Regulatory agency</a></td>
      <td>A regulatory agency (regulatory body, regulator) or independent agency (independent regulatory agency) is a government authority that is responsible for exercising autonomous dominion over some area of human activity in a licensing and regulating capacity.\nThese are customarily set up to strengthen safety and standards, and/or to protect consumers in markets where there is a lack of effective competition.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_capture">Regulatory capture</a></td>
      <td>In politics, regulatory capture (also agency capture and client politics) is a form of corruption of authority that occurs when a political entity, policymaker, or regulator is co-opted to serve the commercial, ideological, or political interests of a minor constituency, such as a particular geographic area, industry, profession, or ideological group.When regulatory capture occurs, a special interest is prioritized over the general interests of the public, leading to a net loss for society. The theory of client politics is related to that of rent-seeking and political failure; client politics "occurs when most or all of the benefits of a program go to some single, reasonably small interest (e.g., industry, profession, or locality) but most or all of the costs will be borne by a large number of people (for example, all taxpayers)".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_sequence">Regulatory sequence</a></td>
      <td>A regulatory sequence is a segment of a nucleic acid molecule which is capable of increasing or decreasing the expression of specific genes within an organism. Regulation of gene expression is an essential feature of all living organisms and viruses.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_T_cell">Regulatory T cell</a></td>
      <td>The regulatory T cells (Tregs  or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_sign">Regulatory sign</a></td>
      <td>A regulatory sign is used to indicate or reinforce traffic laws, regulations or requirements which apply either at all times or at specified times or places upon a street or highway, the disregard of which may constitute a violation, or a sign in general that regulates public behavior in places open to the public.  The FHWA defines regulatory sign as "a sign that gives notice to road users of traffic laws or regulations".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regulatory_law">Regulatory law</a></td>
      <td>Regulatory law refers to secondary legislation, including regulations, promulgated by an executive branch agency under a delegation from a legislature. It contrasts with statutory law promulgated by the legislative branch, and common law or case law promulgated by the judicial branch.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Discounted_cash_flow">Discounted cash flow</a></td>
      <td>In finance, discounted cash flow (DCF) analysis is a method of valuing a security, project, company, or asset using the concepts of the time value of money. \nDiscounted cash flow analysis is widely used in investment finance, real estate development, corporate financial management and patent valuation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operating_cash_flow">Operating cash flow</a></td>
      <td>In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long-term investment on capital items or investment in securities. Operating activities include any spending or sources of cash that’s involved in a company’s day-to-day business activities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Net_present_value">Net present value</a></td>
      <td>The net present value (NPV) or net present worth (NPW) applies to a series of cash flows occurring at different times. The present value of a cash flow depends on the interval of time between now and the cash flow.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Free_cash_flow_to_equity">Free cash flow to equity</a></td>
      <td>In corporate finance, free cash flow to equity (FCFE) is a metric of how much cash can be distributed to the equity shareholders of the company as dividends or stock buybacks—after all expenses, reinvestments, and debt repayments are taken care of. It is also referred to as the levered free cash flow or the flow to equity (FTE).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cash_flow_forecasting">Cash flow forecasting</a></td>
      <td>Cash flow forecasting  is the process of obtaining an estimate or forecast of a company's future financial position; the cash flow forecast is typically based on anticipated payments and receivables.\nSee Financial forecast for general discussion re methodology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cash_Flow_(song)">Cash Flow (song)</a></td>
      <td>"Cash Flow" is the debut single from rapper Ace Hood's debut album Gutta. It is a hip hop song that features T-Pain, Rick Ross and DJ Khaled with a quick intro.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/International_Financial_Reporting_Standards">International Financial Reporting Standards</a></td>
      <td>International Financial Reporting Standards, commonly called IFRS, are accounting standards issued by the IFRS Foundation and the International Accounting Standards Board (IASB). They constitute a standardised way of describing the company's financial performance and position so that company financial statements are understandable and comparable across international boundaries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_position_of_the_United_States">Financial position of the United States</a></td>
      <td>The financial position of the United States includes assets of at least $269.6 trillion (1576% of GDP) and debts of $145.8 trillion (852% of GDP) to produce a net worth of at least $123.8 trillion (723% of GDP) as of Q1 2014.\nThe U.S. increased the ratio of public and private debt from 152% GDP in 1980 to peak at 296% GDP in 2008, before falling to 279% GDP by Q2 2011.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Balance_sheet">Balance sheet</a></td>
      <td>In financial accounting, a balance sheet (also known as statement of financial position or statement of financial condition) is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity. Assets, liabilities and ownership equity are listed as of a specific date, such as the end of its financial year.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December">December</a></td>
      <td>December is the twelfth and the final month of the year in the Julian and Gregorian calendars. It is also the last of seven months to have a length of 31 days.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_18">December 18</a></td>
      <td>December 11 is the 345th day of the year (346th in leap years) in the Gregorian calendar;  20 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n220 – Emperor Xian of Han is forced to abdicate the throne by Cao Cao's son Cao Pi, ending the Han dynasty.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_10">December 10</a></td>
      <td>December 10 is the 344th day of the year (345th in leap years) in the Gregorian calendar;  21 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n1317 – The "Nyköping Banquet": King Birger of Sweden treacherously seizes his two brothers Valdemar, Duke of Finland and Eric, Duke of Södermanland, who were subsequently starved to death in the dungeon of Nyköping Castle.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_1924_German_federal_election">December 1924 German federal election</a></td>
      <td>Federal elections were held in Germany on 7 December 1924, the second that year after the Reichstag had been dissolved on 20 October. The Social Democratic Party remained the largest party in the Reichstag, receiving an increased share of the vote and winning 131 of the 493 seats.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_31">December 31</a></td>
      <td>December 3 is the 337th day of the year (338th in leap years) in the Gregorian calendar;  28 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n915 – Pope John X crowns Berengar I of Italy as Holy Roman Emperor (probable date).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Subsidiary_alliance">Subsidiary alliance</a></td>
      <td>A subsidiary alliance, in South Asian history, was a tributary alliance between an Indian state and a European East India Company. The system of subsidiary alliances was pioneered by the French East India Company governor Joseph François Dupleix, who in the late 1740s established treaties with the Nizam of Hyderabad, India, and other Indian princes in the Carnatic.It stated that the Indian rulers who formed a treaty with the British would be provided with protection against any external attacks in place that the rulers were (a) required to keep the British army at the capitals of their states (b)they were either to give either money or some territory to the company for the maintenance of the British troops (c) they were to turn out from their states all non-english europeans whether they were employed in the army or in the civil service and (d)they had to keep a British official called 'resident' at the capital of their respective states who would oversee all the negotiations and talks with the other states which meant that the rulers were to have no direct correspondence or relations with the other states .</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Subsidiary_title">Subsidiary title</a></td>
      <td>A subsidiary title is an hereditary title held by a royal or noble person but which is not regularly used to identify that person, due to the concurrent holding of a greater title.\n\n\n== United Kingdom ==\nAn example in the United Kingdom is the Duke of Norfolk, who is also the Earl of Arundel, the Earl of Surrey, the Earl of Norfolk, the Baron Beaumont, the Baron Maltravers, the Baron FitzAlan, the Baron Clun, the Baron Oswaldestre, and the Baron Howard of Glossop.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Subsidiary_right">Subsidiary right</a></td>
      <td>A subsidiary right (also called a subright or sub-lease) is the right to produce or publish a product in different formats based on the original material. Subsidiary rights are common in the publishing and entertainment industries, in which subsidiary rights are granted by the author to an agent, publisher, newspaper, or film studio.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Toshiba_subsidiaries">List of Toshiba subsidiaries</a></td>
      <td>Subsidiaries of Toshiba. Together, these companies form the Toshiba Group.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>HUMANA INC      ITEM 1A RISK FACTORS        This document includes <font color="blue">both historical</font> and forward-looking statements</td>
    </tr>
    <tr>
      <td>The     forward-looking statements are made within the meaning of Section 27A of the     <font color="blue">Securities Act </font>of 1933 <font color="blue">and Section </font>21E of the <font color="blue">Securities Exchange Act </font>of     1934</td>
    </tr>
    <tr>
      <td>We intend such forward-looking statements to be <font color="blue">covered by</font> the safe     harbor provisions for forward-looking statements contained in the Private     Securities  Litigation  Reform  Act of 1995, and we are including this     statement for purposes of complying with these safe harbor provisions</td>
    </tr>
    <tr>
      <td>We     have based these forward-looking statements on our <font color="blue">current expectations</font> and     <font color="blue">projections</font>  about  future  events,  trends  and  <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>forward-looking statements are not <font color="blue">guarantees</font> of <font color="blue">future performance</font> and are     subject to risks, <font color="blue">uncertainties</font> and <font color="blue">assumptions</font>, including, among other     things, the information discussed below</td>
    </tr>
    <tr>
      <td>In making these statements, we are     not  undertaking to address or update each factor in <font color="blue">future filings</font> or     <font color="blue">communications</font> regarding our business or results</td>
    </tr>
    <tr>
      <td>Our business is highly     complicated, regulated and <font color="blue">competitive with</font> many <font color="blue">different factors affecting</font>     results</td>
    </tr>
    <tr>
      <td>If the premiums we charge are insufficient to cover the cost of <font color="blue">health care</font>     services delivered to our members, or if our estimates of medical claim     reserves based upon our estimates of future medical claims are inadequate,     our <font color="blue">profitability</font> could decline</td>
    </tr>
    <tr>
      <td>We use a <font color="blue">significant</font> portion of our revenues to pay the costs of <font color="blue">health care</font>     services delivered to our members</td>
    </tr>
    <tr>
      <td>These costs include claims payments,     capitation payments, allocations of some <font color="blue">centralized expenses</font> and various     other <font color="blue">costs incurred</font> to <font color="blue">provide health <font color="blue">insurance coverage</font></font> to our members</td>
    </tr>
    <tr>
      <td>These <font color="blue">costs also</font> include estimates of <font color="blue">future payments</font> to hospitals and     others for <font color="blue">medical care provided</font> to our members</td>
    </tr>
    <tr>
      <td>Generally, premiums in the     <font color="blue">health care</font> business are fixed for one-year periods</td>
    </tr>
    <tr>
      <td>Accordingly, costs we     incur in excess of our <font color="blue">medical cost</font> <font color="blue">projections</font> generally are not recovered     in the <font color="blue">contract year through higher premiums</font></td>
    </tr>
    <tr>
      <td>We estimate the costs of our     future  medical  claims and other <font color="blue">expenses using actuarial methods</font> and     <font color="blue">assumptions</font> based upon claim payment patterns, medical inflation, historical     <font color="blue">developments</font>, including claim <font color="blue">inventory levels</font> and claim <font color="blue">receipt patterns</font>,     and other <font color="blue">relevant factors</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">also record medical</font> claims reserves for     <font color="blue">future payments</font></td>
    </tr>
    <tr>
      <td>We <font color="blue"><font color="blue">continually</font> review</font> estimates of <font color="blue">future payments</font> relating     to medical claims costs for <font color="blue">services incurred</font> in the current and prior     periods  and make <font color="blue">necessary <font color="blue">adjustment</font>s</font> to our reserves</td>
    </tr>
    <tr>
      <td>However, many     <font color="blue">factors may</font> and often do cause actual <font color="blue">health care</font> costs to exceed what was     estimated and used to set our premiums</td>
    </tr>
    <tr>
      <td>These <font color="blue">factors may</font> include:           •   <font color="blue">increased use</font> of medical facilities and services, including     <font color="blue"><font color="blue">prescription drug</font>s</font>;           •   <font color="blue">increased cost</font> of <font color="blue">such services</font>;           •   our <font color="blue">membership</font> mix;           •   variances in <font color="blue">actual versus</font> estimated levels of <font color="blue">cost associated with</font>     <font color="blue">new products</font>, benefits or lines of business, product changes or benefit     level changes;           •   <font color="blue">membership</font> in markets lacking adequate <font color="blue">provider networks</font>;                                           17     ______________________________________________________________________    [39]Table of <font color="blue">Contents       </font>  •   changes in the <font color="blue">demographic characteristics</font> of an account or market;           •   <font color="blue">termination</font> of <font color="blue">capitation arrangements</font> resulting in the transfer of     <font color="blue">membership</font> to fee-for-service arrangements;           •   changes or <font color="blue">reductions</font> of our <font color="blue">utilization management functions such as</font>     <font color="blue">preauthorization</font> of services, concurrent review or <font color="blue">requirements</font> for     <font color="blue">physician referrals</font>;           •   possible changes in our <font color="blue">pharmacy rebate program with drug</font>     <font color="blue">manufacturers</font>;           •   <font color="blue">catastrophes</font>, including acts of terrorism, public health epidemics, or     severe weather (eg Hurricane Katrina);           •   the <font color="blue">introduction</font> of new or costly <font color="blue">treatments</font>, including new     <font color="blue">technologies</font>;           •   <font color="blue">medical cost</font> inflation; and           •   <font color="blue">government</font> <font color="blue">mandated benefits</font> or other <font color="blue">regulatory</font> changes</td>
    </tr>
    <tr>
      <td>Failure to <font color="blue">adequately</font> price our products or estimate sufficient medical     claim reserves may result in a material adverse effect on our financial     position, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>If we do not design and price our <font color="blue">products properly</font> and <font color="blue">competitively</font>, our     <font color="blue">membership</font> and <font color="blue">profitability</font> could decline</td>
    </tr>
    <tr>
      <td>We are in a <font color="blue">highly competitive industry</font></td>
    </tr>
    <tr>
      <td>Many of our <font color="blue">competitors</font> are more     established in the <font color="blue">health care</font> industry in terms of a <font color="blue">larger market</font> share     and  have  greater  <font color="blue">financial resources than</font> we do in some markets</td>
    </tr>
    <tr>
      <td>In     addition, other <font color="blue">companies may enter</font> our markets in the future, including     emerging <font color="blue">competitors</font> in the Medicare program and in consumer-choice health     plans, <font color="blue">such as high deductible health</font> plans with HSAs</td>
    </tr>
    <tr>
      <td>We believe that     barriers to entry in many markets are not substantial, so the addition of     new <font color="blue">competitors</font> can occur <font color="blue">relatively easily</font>, and customers enjoy <font color="blue">significant</font>     <font color="blue">flexibility</font>  in  moving between <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td><font color="blue">Contracts </font>for the sale of     <font color="blue">commercial products</font> are <font color="blue">generally bid upon</font> or <font color="blue">renewed annually</font></td>
    </tr>
    <tr>
      <td>While health     plans  <font color="blue">compete on</font> the basis of many factors, including service and the     quality and depth of <font color="blue">provider networks</font>, we expect that <font color="blue">price will continue</font>     to be a <font color="blue">significant</font> basis of <font color="blue">competition</font></td>
    </tr>
    <tr>
      <td>In addition to the challenge of     controlling <font color="blue">health care</font> costs, we <font color="blue">face intense competitive pressure</font> to     <font color="blue">contain premium prices</font></td>
    </tr>
    <tr>
      <td>Factors such as business consolidations, strategic     alliances, <font color="blue">legislative</font> reform and <font color="blue">marketing practices</font> create pressure to     contain premium price increases, despite being <font color="blue">faced with increasing medical</font>     costs</td>
    </tr>
    <tr>
      <td>The commercial pricing environment, <font color="blue">particularly</font> in the 2 to 300     member  groups,  is <font color="blue">extremely competitive</font></td>
    </tr>
    <tr>
      <td>Several of our <font color="blue">competitors</font>,     including public and not-for-profit companies, are pricing <font color="blue">aggressively</font> to     gain market share</td>
    </tr>
    <tr>
      <td>Premium increases, <font color="blue">introduction</font> of <font color="blue">new product designs</font>, and our <font color="blue">relationship</font>     with our providers in <font color="blue">various markets</font>, among other issues, could also affect     our <font color="blue">membership</font> levels</td>
    </tr>
    <tr>
      <td>Other actions that could affect <font color="blue">membership</font> levels     include our <font color="blue">possible exit from</font> or <font color="blue">entrance into</font> <font color="blue">Medicare or <font color="blue">Commercial </font>    </font>markets, or the <font color="blue">termination</font> of a large contract, including our <font color="blue">TRICARE     </font>contract</td>
    </tr>
    <tr>
      <td>If we do not <font color="blue">compete <font color="blue"><font color="blue">effective</font>ly</font></font> in our markets, if we <font color="blue">set rates too high</font> or     too low in <font color="blue">highly competitive markets</font> to keep or increase our market share,     if <font color="blue">membership</font> does not <font color="blue">increase as</font> we expect, if <font color="blue">membership</font> declines, or if     we <font color="blue">lose accounts with</font> favorable <font color="blue">medical cost</font> experience while retaining or     increasing <font color="blue">membership</font> in accounts with unfavorable <font color="blue">medical cost</font> experience,     our  business  and results of <font color="blue">operations</font> could be <font color="blue"><font color="blue">materially</font> <font color="blue">adversely</font></font>     affected</td>
    </tr>
    <tr>
      <td>If  we  fail  to  <font color="blue"><font color="blue">effective</font>ly</font>  implement our operational and strategic     <font color="blue">initiatives</font>, our business could be <font color="blue"><font color="blue">materially</font> <font color="blue">adversely</font></font> affected</td>
    </tr>
    <tr>
      <td>Our <font color="blue">future performance</font> depends in large part upon our management team’s     ability to execute our strategy to position the Company for the future</td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>strategy includes <font color="blue">opportunities</font> created by the <font color="blue">MMA The MMA </font>offers new     <font color="blue">opportunities</font> in our Medicare programs, including our HMO, PPO, and PFFS     <font color="blue">Medicare Advantage </font>                                          18     ______________________________________________________________________    [40]Table of <font color="blue">Contents       </font>products, as well as our PDP products</td>
    </tr>
    <tr>
      <td>We have made substantial <font color="blue">additional</font>     <font color="blue">investments</font> in the Medicare program to enhance our ability to <font color="blue">participate</font> in     these <font color="blue">expanded programs</font></td>
    </tr>
    <tr>
      <td>We have doubled the size of our Medicare geographic     <font color="blue">reach since</font> the <font color="blue">enactment</font> of the MMA <font color="blue">through expanded</font> Medicare product     offerings</td>
    </tr>
    <tr>
      <td>We are <font color="blue">offering both</font> the stand-alone Medicare Prescription Drug     Coverage (PDP) and <font color="blue">Medicare Advantage </font>Health Plan with Prescription Drug     Coverage (MA-PD) in addition to our other product offerings</td>
    </tr>
    <tr>
      <td><font color="blue">Our Medicare     </font>presence  as  of <font color="blue">February </font>1, 2006, included more than 700cmam000 Medicare     Advantage  members and <font color="blue">approximately</font> 1dtta7 million PDP members in 12 HMO     markets, 33 local PPO markets, and 35 states in which we have a private     fee-for-service offering</td>
    </tr>
    <tr>
      <td><font color="blue">Enrollment </font>in the new Part D <font color="blue">prescription drug</font>     plans <font color="blue">began on</font> November 15, 2005, and the plans <font color="blue">became <font color="blue">effective</font></font> January 1,     2006</td>
    </tr>
    <tr>
      <td>We have <font color="blue">been approved</font> to offer the Medicare <font color="blue">prescription drug</font> plan in     46 states and the <font color="blue">District of Columbia</font></td>
    </tr>
    <tr>
      <td>The timing of our new <font color="blue">membership</font> enrollment in our <font color="blue">Medicare Advantage </font>and     PDP products is an important factor in meeting our business <font color="blue">objectives</font></td>
    </tr>
    <tr>
      <td>The     pattern of <font color="blue">quarterly earnings</font> for 2006 is subject to certain <font color="blue">assumptions</font>     including the timing of when a member enrolls in a plan, the plan type the     member selects, and the <font color="blue">speed with which</font> the individual <font color="blue">members meet</font> their     <font color="blue">deductibles</font> and cost-sharing provisions</td>
    </tr>
    <tr>
      <td>We have also made substantial <font color="blue">investments</font> in the <font color="blue">service personnel</font> and     <font color="blue"><font color="blue">technology</font> necessary</font> to <font color="blue">administer</font> the growing Medicare business</td>
    </tr>
    <tr>
      <td><font color="blue">Service     </font><font color="blue">issues intensified due</font> to an enormous number of <font color="blue">individuals</font> being eligible     in the <font color="blue">new program on</font> January 1</td>
    </tr>
    <tr>
      <td>We have to implement various <font color="blue">initiatives</font>     such as hiring <font color="blue">additional</font> service representatives to address the service     issues</td>
    </tr>
    <tr>
      <td>Any failure to achieve this <font color="blue">growth may</font> have a material adverse     effect on our <font color="blue">financial position</font>, results of <font color="blue">operations</font> or <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>In     addition, the expansion of our Medicare business in relation to our other     <font color="blue"><font color="blue">businesses</font> may intensify</font> the risks to us inherent in the Medicare business,     which are <font color="blue">described elsewhere</font> in this document</td>
    </tr>
    <tr>
      <td>These <font color="blue">expansion efforts may</font>     result in <font color="blue">less diversification</font> of our <font color="blue">revenue stream</font></td>
    </tr>
    <tr>
      <td>Additionally, our strategy includes the growth of our <font color="blue">Commercial </font>segment     business, <font color="blue">with emphasis on</font> our ASO and individual products, <font color="blue">introduction</font> of     <font color="blue">new products</font> and benefit designs, including our Smart, consumer-choice     <font color="blue">products such as</font> HSAs as well as the adoption of new <font color="blue">technologies</font> and the     <font color="blue">integration</font> of acquired <font color="blue">businesses</font> and contracts</td>
    </tr>
    <tr>
      <td>There can be no assurance that we will be able to <font color="blue">successfully</font> implement our     operational and strategic <font color="blue">initiatives</font> that are intended to <font color="blue">position us</font> for     <font color="blue">future growth</font> or that the products we <font color="blue">design will</font> be accepted or adopted in     the time periods assumed</td>
    </tr>
    <tr>
      <td>Failure to implement this strategy may result in a     material adverse effect on our <font color="blue">financial position</font>, results of <font color="blue">operations</font> and     <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>If we fail to properly maintain the integrity of our data, to <font color="blue">strategically</font>     implement new information systems, or to protect our <font color="blue"><font color="blue">proprietary</font> rights</font> to     our systems, our business could be <font color="blue"><font color="blue">materially</font> <font color="blue">adversely</font></font> affected</td>
    </tr>
    <tr>
      <td>Our business depends <font color="blue">significant</font>ly on <font color="blue">effective</font> information systems and the     integrity  and  <font color="blue">timeliness</font> of the data we use to run our business</td>
    </tr>
    <tr>
      <td>Our     business <font color="blue">strategy involves providing members</font> and <font color="blue">providers with easy</font> to use     products that leverage our information to meet their needs</td>
    </tr>
    <tr>
      <td>Our ability to     <font color="blue">adequately</font> price our products and services, provide <font color="blue">effective</font> and <font color="blue">efficient</font>     service to our customers, and to timely and <font color="blue">accurately</font> report our financial     results  depends  <font color="blue">significant</font>ly  on  the  integrity of the data in our     information  systems</td>
    </tr>
    <tr>
      <td>As a result of our past and on-going <font color="blue">acquisition</font>     <font color="blue">activities</font>, we have acquired <font color="blue">additional</font> information systems</td>
    </tr>
    <tr>
      <td>We have been     taking steps to reduce the number of systems we operate, have upgraded and     expanded our information <font color="blue">systems <font color="blue">capabilities</font></font>, and are <font color="blue">gradually migrating</font>     existing business to <font color="blue">fewer systems</font></td>
    </tr>
    <tr>
      <td>Our information systems require an     <font color="blue">ongoing commitment</font> of <font color="blue">significant</font> resources to maintain, protect and enhance     existing  systems and develop <font color="blue">new systems</font> to keep <font color="blue">pace with continuing</font>     changes  in  information  processing <font color="blue">technology</font>, evolving industry and     <font color="blue">regulatory</font> standards, and changing <font color="blue">customer preferences</font></td>
    </tr>
    <tr>
      <td>If the information     we rely upon to run our <font color="blue">businesses</font>                                           19     ______________________________________________________________________    [41]Table of <font color="blue">Contents       </font>was  found  to  be  <font color="blue">inaccurate</font> or unreliable or if we fail to maintain     <font color="blue"><font color="blue">effective</font>ly</font>  our information systems and <font color="blue">data integrity</font>, we could have     <font color="blue">operational <font color="blue">disruption</font>s</font>, have problems in determining <font color="blue">medical cost</font> estimates     and <font color="blue"><font color="blue">establishing</font> appropriate pricing</font>, have customer and physician and other     <font color="blue">health care</font> provider disputes, have <font color="blue">regulatory</font> or other <font color="blue">legal problems</font>, have     increases in operating expenses, lose existing customers, have <font color="blue"><font color="blue">difficult</font>y</font> in     <font color="blue">attracting new customers</font>, or suffer other <font color="blue">adverse consequences</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on independent third parties</font> for <font color="blue">significant</font> portions of our     systems-related support, equipment, facilities, and <font color="blue">certain data</font>, including     data center <font color="blue">operations</font>, data network, voice <font color="blue">communication services</font> and     <font color="blue">pharmacy data processing</font></td>
    </tr>
    <tr>
      <td>This dependence makes our <font color="blue">operations</font> vulnerable to     such third parties’ failure to perform <font color="blue">adequately</font> under the contract, due to     internal  or <font color="blue">external factors</font></td>
    </tr>
    <tr>
      <td>We have recently changed vendors in our     <font color="blue">pharmacy benefits program</font></td>
    </tr>
    <tr>
      <td>A change in <font color="blue">service providers could</font> result in a     decline in <font color="blue">service quality</font> and <font color="blue"><font color="blue">effective</font>ness</font> or less favorable contract     <font color="blue">terms which could <font color="blue">adversely</font> affect</font> our operating results</td>
    </tr>
    <tr>
      <td>We rely on our <font color="blue">agreements</font> with customers, <font color="blue">confidentiality</font> <font color="blue">agreements</font> with     employees, and our <font color="blue">trade secrets</font> and <font color="blue">copyrights</font> to protect our <font color="blue">proprietary</font>     rights</td>
    </tr>
    <tr>
      <td>These  legal  <font color="blue">protections</font>  and  <font color="blue">precautions</font>  may  not prevent     <font color="blue">misappropriation</font> of our <font color="blue">proprietary</font> information</td>
    </tr>
    <tr>
      <td>In addition, substantial     <font color="blue">litigation</font> regarding <font color="blue">intellectual property rights</font> exists in the software     industry</td>
    </tr>
    <tr>
      <td>We  expect  <font color="blue">software products</font> to be increasingly subject to     third-party infringement claims as the number of products and <font color="blue">competitors</font> in     this <font color="blue">area grows</font></td>
    </tr>
    <tr>
      <td>Our business plans also include becoming a quality e-business organization     by  enhancing  interactions with customers, brokers, agents, and other     <font color="blue">stakeholders</font> through web-enabling <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Our strategy includes sales     and  <font color="blue">distribution</font> of <font color="blue">health benefit products through</font> the Internet, and     <font color="blue">implementation</font> of advanced self-service <font color="blue">capabilities</font>, for internal and     external <font color="blue">stakeholders</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that our process of <font color="blue">improving existing systems</font>,     developing <font color="blue">new systems</font> to support our expanding <font color="blue">operations</font>, integrating new     systems, protecting our <font color="blue">proprietary</font> information, and <font color="blue">improving service</font>     <font color="blue">levels will</font> not be delayed or that <font color="blue">additional</font> systems issues will not arise     in the future</td>
    </tr>
    <tr>
      <td>Failure to <font color="blue">adequately</font> protect and maintain the integrity of     our information systems and data may result in a material adverse effect on     our <font color="blue">financial position</font>s, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>We are involved in various <font color="blue">legal actions</font>, which, if <font color="blue">resolved <font color="blue">unfavorably</font></font> to     us, could result in substantial <font color="blue">monetary damages</font></td>
    </tr>
    <tr>
      <td>We are a party to a variety of <font color="blue">legal actions</font> that affect our business,     including <font color="blue">employment</font> and <font color="blue">employment</font> discrimination-related suits, employee     benefit claims, breach of <font color="blue">contract actions</font>, and tort claims</td>
    </tr>
    <tr>
      <td>In addition, because of the nature of the <font color="blue">health care</font> business, we are     subject to a variety of <font color="blue">legal actions</font> relating to our business <font color="blue">operations</font>,     including the design, management and offering of products and services</td>
    </tr>
    <tr>
      <td>These include and could include in the future:           •   claims relating to the <font color="blue">methodologies</font> for <font color="blue">calculating premiums</font>;           •   claims relating to the denial of <font color="blue">health care</font> benefit payments;           •   claims relating to the denial or <font color="blue">rescission</font> of <font color="blue">insurance coverage</font>;           •   <font color="blue">challenges</font> to the use of some <font color="blue">software products</font> used in <font color="blue">administer</font>ing     claims;           •   <font color="blue">medical malpractice actions <font color="blue">based on</font></font> our <font color="blue">medical necessity decisions</font>     or <font color="blue">brought against us on</font> the theory that we are liable for our providers’     alleged malpractice;           •   <font color="blue">allegations</font> of anti-competitive and unfair business <font color="blue">activities</font>;           •   <font color="blue">provider disputes over compensation</font> and <font color="blue">termination</font> of provider     contracts;           •   disputes related to ASO business, including actions alleging claim     <font color="blue">administration errors</font>;                                           20     ______________________________________________________________________    [42]Table of <font color="blue">Contents       </font>  •   claims related to the failure to disclose some business practices; and           •   claims relating to <font color="blue">customer audits</font> and <font color="blue">contract performance</font></td>
    </tr>
    <tr>
      <td>In some cases, substantial non-economic or <font color="blue">punitive damages as well as</font>     <font color="blue">treble damages under</font> the federal False Claims Act, Rackateer Influenced and     Corrupt  Organizations  Act and other <font color="blue">statutes may</font> be sought</td>
    </tr>
    <tr>
      <td>While we     currently have <font color="blue">insurance coverage</font> for some of these <font color="blue">potential liabilities</font>,     other <font color="blue">potential liabilities</font> may not be <font color="blue">covered by</font> insurance, insurers may     <font color="blue">dispute coverage</font> or the amount of our <font color="blue">insurance may</font> not be enough to cover     the <font color="blue">damages awarded</font></td>
    </tr>
    <tr>
      <td>Additionally, the cost of business <font color="blue">insurance coverage</font>     has increased <font color="blue">significant</font>ly</td>
    </tr>
    <tr>
      <td>As a result, we have increased the amount of     risk that we self-insure, <font color="blue">particularly</font> with respect to matters <font color="blue">incidental</font> to     our business</td>
    </tr>
    <tr>
      <td>In addition, some types of damages, like punitive damages, may     not be <font color="blue">covered by</font> insurance</td>
    </tr>
    <tr>
      <td>In some jurisdictions, coverage of punitive     damages is prohibited</td>
    </tr>
    <tr>
      <td>Insurance coverage for all or some forms of <font color="blue">liability</font>     <font color="blue">may become unavailable</font> or <font color="blue">prohibitively expensive</font> in the future</td>
    </tr>
    <tr>
      <td>A description of material <font color="blue">legal actions</font> in which we are <font color="blue">currently involved</font>     is  included  under  “Legal  Proceedings”  in Note 14 to the condensed     <font color="blue">consolidated financial statements</font> included in Item 8</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot predict</font> the outcome of these suits with     <font color="blue">certainty</font>, and we are <font color="blue">incurring expenses</font> in the defense of these matters</td>
    </tr>
    <tr>
      <td>Therefore, these <font color="blue">legal actions</font> could have a material adverse effect on our     <font color="blue">financial position</font>, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>As a <font color="blue">government</font> <font color="blue">contractor</font>, we are exposed to <font color="blue">additional</font> risks that could     <font color="blue">adversely</font>  affect  our  business  or our <font color="blue">willingness</font> to <font color="blue">participate</font> in     <font color="blue">government</font> <font color="blue">health care</font> programs</td>
    </tr>
    <tr>
      <td>A  <font color="blue">significant</font>  portion  of  our revenues relates to federal and state     <font color="blue">government</font> <font color="blue">health care</font> coverage programs, including the Medicare, TRICARE,     and Medicaid programs</td>
    </tr>
    <tr>
      <td><font color="blue">Our <font color="blue">Government Segment </font></font>accounted for <font color="blue">approximately</font>     53prca of our <font color="blue">total premiums</font> and ASO fees for the year ended <font color="blue">December </font>31, 2005     and we expect the <font color="blue">Government Segment </font>to account for a <font color="blue">greater percentage</font> of     our <font color="blue">total premiums</font> and ASO fees in 2006</td>
    </tr>
    <tr>
      <td>These <font color="blue">programs involve various</font>     risks, including:           •   at <font color="blue">December </font>31, 2005, under our <font color="blue">contracts with</font> CMS we <font color="blue">provided health</font>     <font color="blue">insurance coverage</font> to <font color="blue">approximately</font> 295cmam400 members in Florida</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">contracts accounted</font> for <font color="blue">approximately</font> 20prca of our <font color="blue">total premiums</font> and ASO fees     for the year ended <font color="blue">December </font>31, 2005</td>
    </tr>
    <tr>
      <td>The loss of these and other CMS     contracts or <font color="blue">significant</font> changes in the Medicare <font color="blue">program as</font> a result of     <font color="blue">legislative</font> or <font color="blue">administrative action</font>, including <font color="blue">reductions</font> in payments to us     or increases in benefits to <font color="blue">members without corresponding increases</font> in     payments, may have a material adverse effect on our <font color="blue">financial condition</font>,     results of <font color="blue">operations</font> and <font color="blue">cash flows</font>;           •   at <font color="blue">December </font>31, 2005, our TRICARE business, <font color="blue">which accounted</font> for     <font color="blue">approximately</font> 17prca of our <font color="blue">total premiums</font> and ASO <font color="blue">fees during</font> the year ended     <font color="blue">December </font>31, 2005, primarily consisted of the <font color="blue">South Region </font>contract</td>
    </tr>
    <tr>
      <td>The     <font color="blue">South Region </font>contract is a five-year contract, subject to <font color="blue">annual renewals at</font>     the Government’s option, with the the <font color="blue">third option period scheduled</font> to begin     April 1, 2006, that covers <font color="blue">approximately</font> 2dtta9 million beneficiaries</td>
    </tr>
    <tr>
      <td>The loss     of our current TRICARE <font color="blue">contract would</font> have a material adverse effect on our     <font color="blue">financial position</font>, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>This contract     <font color="blue">contains provisions</font> to negotiate a target <font color="blue">health care</font> cost amount annually     with the federal <font color="blue">government</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">variance from</font> the target <font color="blue">health care</font> cost     is <font color="blue">shared with</font> the federal <font color="blue">government</font></td>
    </tr>
    <tr>
      <td>As such, events and <font color="blue">circumstances</font> not     contemplated in the negotiated target <font color="blue">health care</font> cost amount could have a     material adverse effect on our business</td>
    </tr>
    <tr>
      <td>These changes may include, for     example, an increase or reduction in the number of <font color="blue">persons enrolled</font> or     eligible to <font color="blue">enroll due</font> to the federal <font color="blue">government</font>’s decision to increase or     decrease US <font color="blue">military presence around</font> the world</td>
    </tr>
    <tr>
      <td>In the event <font color="blue">government</font>     <font color="blue">reimbursements</font> were to decline from projected amounts, our failure to reduce     the <font color="blue">health care</font> costs associated with these programs could have a material     adverse effect on our business;           •       at <font color="blue">December </font>31, 2005, under our <font color="blue">contracts with</font> the <font color="blue">Puerto Rico </font>Health     Insurance Administration, we <font color="blue">provided health</font> <font color="blue">insurance coverage</font> to     <font color="blue">approximately</font> 403cmam100 Medicaid members in Puerto Rico</td>
    </tr>
    <tr>
      <td>These contracts     accounted for <font color="blue">approximately</font> 3prca of our <font color="blue">total premiums</font> and ASO fees for the     year ended                                           21     ______________________________________________________________________    [43]Table of <font color="blue">Contents       </font>    <font color="blue">December </font>31, 2005</td>
    </tr>
    <tr>
      <td>We currently have Medicaid <font color="blue">contracts with</font> the <font color="blue">Puerto Rico </font>    Health Insurance Administration that expire on June 30, 2006</td>
    </tr>
    <tr>
      <td>We are     preparing to bid on the <font color="blue">new contracts</font> that will be <font color="blue">effective</font> July 2006     although a request for <font color="blue">such proposal</font> has not <font color="blue">yet been issued by</font> the Puerto     Rico Health Insurance Administration</td>
    </tr>
    <tr>
      <td>The loss of these contracts or     <font color="blue">significant</font> changes in the <font color="blue"><font color="blue">Puerto Rico </font>Medicaid </font><font color="blue">program as</font> a result of     <font color="blue">legislative</font> or <font color="blue">administrative action</font>, including <font color="blue">reductions</font> in payments to us     or increases in benefits to <font color="blue">members without corresponding increases</font> in     payments, may have a material adverse effect on our <font color="blue">financial condition</font>,     results of <font color="blue">operations</font> and <font color="blue">cash flows</font>;           •   the <font color="blue">possibility</font> of temporary or <font color="blue">permanent suspension from</font>     <font color="blue">participating</font> in <font color="blue">government</font> <font color="blue">health care</font> programs, including Medicare and     Medicaid, if we are convicted of fraud or other <font color="blue">criminal conduct</font> in the     performance of a <font color="blue">health care</font> program or if there is an <font color="blue">adverse decision</font>     <font color="blue">against us under</font> the federal False Claims Act;           •   CMS has implemented a <font color="blue">risk <font color="blue">adjustment</font> model which apportions premiums</font>     paid to Medicare health plans <font color="blue">according</font> to <font color="blue">health severity</font></td>
    </tr>
    <tr>
      <td>A risk     <font color="blue"><font color="blue">adjustment</font> model pays</font> more for <font color="blue">enrollees with predictably higher costs</font></td>
    </tr>
    <tr>
      <td>Under the new risk <font color="blue">adjustment</font> <font color="blue">methodology</font>, all Medicare health plans must     collect, capture and submit the <font color="blue">necessary diagnosis code</font> information from     inpatient and <font color="blue">ambulatory treatment settings</font> to CMS <font color="blue">within prescribed</font>     <font color="blue">deadlines</font></td>
    </tr>
    <tr>
      <td>The CMS risk <font color="blue">adjustment</font> model uses this <font color="blue">diagnosis data</font> to     calculate the <font color="blue">risk adjusted premium payment</font> to Medicare health plans</td>
    </tr>
    <tr>
      <td>CMS is     <font color="blue">transitioning</font> to the risk <font color="blue">adjustment</font> model for <font color="blue">Medicare Advantage </font>plans as     follows: 50prca in 2005, 75prca in 2006 and 100prca in 2007</td>
    </tr>
    <tr>
      <td>The PDP payment     <font color="blue">methodology</font> is based 100prca on the risk <font color="blue">adjustment</font> model beginning in 2006;           •   commensurate with phase-in of the new risk-<font color="blue">adjustment</font> <font color="blue">methodology</font>,     payments to <font color="blue">Medicare Advantage </font>plans have <font color="blue">been increased by</font> a “budget     <font color="blue">neutrality</font>” factor</td>
    </tr>
    <tr>
      <td>The budget <font color="blue">neutrality</font> factor was implemented to prevent     <font color="blue">overall health</font> plan <font color="blue">payments from</font> being <font color="blue">reduced during</font> the transition to the     new risk-<font color="blue">adjustment</font> payment model</td>
    </tr>
    <tr>
      <td>The payment <font color="blue">adjustment</font>s for budget     <font color="blue">neutrality</font> were first developed in 2002 and began to be used with the 2003     payments</td>
    </tr>
    <tr>
      <td>The budget <font color="blue">neutrality</font> <font color="blue">adjustment</font> will begin phasing out in 2007     and will be fully eliminated by 2011</td>
    </tr>
    <tr>
      <td>This does not mean, however, that the     aggregate per-member payments to Medicare plans will be reduced</td>
    </tr>
    <tr>
      <td>As plans     <font color="blue">enroll less healthy beneficiaries</font>, the need for the budget <font color="blue">neutrality</font>     <font color="blue">adjustment</font> declines as the <font color="blue">underlying risk adjusted</font> Medicare rates paid to     plans increase to account for their enrollees’ greater healthcare needs</td>
    </tr>
    <tr>
      <td>As     a result of the CMS payment <font color="blue">methodology</font> described above, the amount and     timing of our CMS <font color="blue">monthly premium payments per</font> member may change <font color="blue">materially</font>,     <font color="blue">either favorably</font> or <font color="blue">unfavorably</font>;           •   future changes to these <font color="blue">government</font> programs which may affect our     ability or <font color="blue">willingness</font> to <font color="blue">participate</font> in these programs;           •   higher comparative <font color="blue">medical cost</font>s;           •   <font color="blue">government</font> <font color="blue">regulatory</font> and reporting <font color="blue">requirements</font>; and           •   <font color="blue">higher marketing</font> and <font color="blue">advertising costs per</font> member as a result of     marketing to <font color="blue">individuals</font> as opposed to groups</td>
    </tr>
    <tr>
      <td>Our industry is currently subject to substantial <font color="blue">government</font> regulation,     which, along with possible increased <font color="blue">government</font>al regulation or <font color="blue">legislative</font>     reform, increases our costs of doing business and could <font color="blue">adversely</font> affect our     <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">health care</font> industry in general, and health insurance, <font color="blue">particularly</font> HMOs     and PPOs are subject to substantial federal and state <font color="blue">government</font> regulation</td>
    </tr>
    <tr>
      <td>Our <font color="blue">licensed <font color="blue">subsidiaries</font></font> are subject to <font color="blue">regulation under</font> state insurance     holding company and <font color="blue">Puerto Rico </font><font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font> generally     require, among other things, prior approval and/or notice of <font color="blue">new products</font>,     rates,  benefit  changes, and certain material <font color="blue">transactions</font>, including     dividend payments, purchases or sales of assets, intercompany <font color="blue">agreements</font>,     and the filing of <font color="blue">various financial</font> and operational reports</td>
    </tr>
    <tr>
      <td>22     ______________________________________________________________________    [44]Table of <font color="blue">Contents       </font>Certain of our <font color="blue">subsidiaries</font> operate in states that regulate the payment of     dividends,  loans,  or other <font color="blue">cash transfers</font> to Humana Inc, our parent     company, and require <font color="blue">minimum levels</font> of equity as well as limit <font color="blue">investments</font>     to <font color="blue">approved securities</font></td>
    </tr>
    <tr>
      <td>by these <font color="blue">subsidiaries</font>, without prior approval by state <font color="blue">regulatory</font>     <font color="blue">authorities</font>, is limited <font color="blue">based on</font> the entity’s level of statutory income and     statutory  capital  and surplus</td>
    </tr>
    <tr>
      <td>In most states, <font color="blue">prior notification</font> is     provided before paying a <font color="blue">dividend even</font> if approval is not required</td>
    </tr>
    <tr>
      <td>As of <font color="blue">December </font>31, 2005, we maintained <font color="blue">aggregate statutory capital</font> and     surplus of dlra1cmam203dtta2 million in our state regulated <font color="blue">subsidiaries</font></td>
    </tr>
    <tr>
      <td>Each of     these <font color="blue">subsidiaries</font> was in compliance with applicable statutory <font color="blue">requirements</font>     which aggregated dlra722dtta2 million</td>
    </tr>
    <tr>
      <td>Although the minimum required levels of     equity are largely <font color="blue">based on</font> <font color="blue">premium volume</font>, product mix, and the quality of     assets held, minimum <font color="blue">requirements</font> can vary <font color="blue">significant</font>ly at the state level</td>
    </tr>
    <tr>
      <td>Given our anticipated <font color="blue">premium growth</font> in 2006 resulting from the expansion of     our Medicare products, capital <font color="blue">requirements</font> will increase</td>
    </tr>
    <tr>
      <td>We expect to fund     these increased <font color="blue">requirements</font> with capital contributions from Humana Inc,     our <font color="blue">parent company</font>, in the range of dlra450 million to dlra650 million in 2006</td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>calculation indicates recommended <font color="blue">minimum levels</font> of required capital and     surplus and signals <font color="blue">regulatory</font> measures should actual surplus fall below     these <font color="blue">recommended levels</font></td>
    </tr>
    <tr>
      <td>If RBC were <font color="blue">adopted by</font> all states and <font color="blue">Puerto Rico </font>    at <font color="blue">December </font>31, 2005, we would be required to fund dlra14dtta7 million in one of     our <font color="blue">Puerto Rico </font><font color="blue">subsidiaries</font> to meet all <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>After this funding,     we would have dlra378dtta2 million of <font color="blue">aggregate capital</font> and surplus above any of     the levels that require <font color="blue">corrective action under</font> RBC       The use of <font color="blue">individually identifiable data by</font> our business is <font color="blue">regulated at</font>     federal and state levels</td>
    </tr>
    <tr>
      <td>These laws and rules are changed <font color="blue"><font color="blue">frequently</font> by</font>     <font color="blue">legislation</font> or <font color="blue">administrative interpretation</font></td>
    </tr>
    <tr>
      <td>Various state <font color="blue">laws address</font> the     use and maintenance of <font color="blue"><font color="blue">individually identifiable health</font> data</font></td>
    </tr>
    <tr>
      <td>Most are     <font color="blue">derived from</font> the <font color="blue">privacy provisions</font> in the federal Gramm-Leach-Bliley Act     and HIPAA HIPAA includes <font color="blue">administrative provisions directed at simplifying</font>     electronic data interchange through standardizing <font color="blue">transactions</font>, <font color="blue">establishing</font>     uniform <font color="blue">health care</font> provider, payer, and <font color="blue">employer identifiers</font> and seeking     <font color="blue">protections</font> for <font color="blue">confidentiality</font> and security of <font color="blue">patient data</font></td>
    </tr>
    <tr>
      <td>The rules do     not  provide for complete <font color="blue">federal preemption</font> of state laws, but rather     preempt all <font color="blue">inconsistent</font> state <font color="blue">laws unless</font> the state law is more stringent</td>
    </tr>
    <tr>
      <td>These  <font color="blue">regulations</font> set standards for the security of <font color="blue">electronic health</font>     information</td>
    </tr>
    <tr>
      <td><font color="blue">Violations </font>of these rules will subject us to <font color="blue">significant</font>     penalties</td>
    </tr>
    <tr>
      <td><font color="blue">Compliance </font>with HIPAA <font color="blue">regulations</font> requires <font color="blue">significant</font> systems     enhancements, training and <font color="blue">administrative effort</font></td>
    </tr>
    <tr>
      <td>HIPAA <font color="blue">could also expose us</font>     to  <font color="blue">additional</font>  <font color="blue">liability</font> for <font color="blue">violations by</font> our business <font color="blue">associates</font></td>
    </tr>
    <tr>
      <td>A     business associate is a person or entity, other than a member of the work     force,  who  on behalf of a covered entity performs, or assists in the     performance of a function or <font color="blue">activity involving</font> the use or <font color="blue">disclosure</font> of     <font color="blue">individually identifiable health</font> information, or provides legal, accounting,     consulting, data aggregation, management, administrative, <font color="blue">accreditation</font>, or     <font color="blue">financial services</font></td>
    </tr>
    <tr>
      <td>Another area receiving <font color="blue">increased focus</font> is the time in <font color="blue">which various laws</font>     require  the  payment  of <font color="blue">health care</font> claims</td>
    </tr>
    <tr>
      <td>Many states already have     <font color="blue">legislation</font> in place <font color="blue">covering payment</font> of claims within a specific number of     days</td>
    </tr>
    <tr>
      <td>However, due to <font color="blue">provider groups advocating</font> for laws or <font color="blue">regulations</font>     <font color="blue">establishing</font> even stricter standards, procedures and penalties, we expect     <font color="blue">additional</font> <font color="blue">regulatory</font> scrutiny and supplemental <font color="blue">legislation</font> with respect to     claims <font color="blue">payment practices</font></td>
    </tr>
    <tr>
      <td>The provider-sponsored bills are <font color="blue">characterized by</font>     <font color="blue">stiff penalties</font> for <font color="blue">late payment</font>, including <font color="blue">high interest rates payable</font> to     providers  and  <font color="blue">costly fines levied by</font> state <font color="blue">insurance departments</font> and     <font color="blue">attorneys general</font></td>
    </tr>
    <tr>
      <td>This <font color="blue">legislation</font> and <font color="blue">possible future regulation</font> and     <font color="blue">oversight could expose us</font> to <font color="blue">additional</font> <font color="blue">liability</font> and penalties</td>
    </tr>
    <tr>
      <td>We are <font color="blue">implementing</font> a mail order pharmacy business that <font color="blue">subjects us</font> to     extensive federal, state and <font color="blue">local regulation</font></td>
    </tr>
    <tr>
      <td>We are also subject to risks     inherent in the packaging and <font color="blue">distribution</font> of <font color="blue">pharmaceuticals</font> and other     <font color="blue">health care</font> products</td>
    </tr>
    <tr>
      <td>23     ______________________________________________________________________    [45]Table of <font color="blue">Contents       </font>We are also subject to various <font color="blue">government</font>al audits and <font color="blue">investigations</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>can include audits and <font color="blue">investigations</font> by state <font color="blue">attorneys general</font>, CMS, the     Office of the Inspector General of Health and Human Services, the Office of     Personnel Management, the Department of Justice, the Department of Labor,     the Defense Contract Audit Agency, and state <font color="blue"><font color="blue">Departments </font>of Insurance </font>and     <font color="blue"><font color="blue">Departments </font>of Health</font></td>
    </tr>
    <tr>
      <td>Several state <font color="blue">attorneys general</font> and <font color="blue">Departments </font>of     Insurance are <font color="blue">currently investigating</font> the practices of <font color="blue">insurance brokers</font>,     including those of certain of the companies in the <font color="blue">health care</font> industry</td>
    </tr>
    <tr>
      <td>All     of these <font color="blue">activities</font> could result in the loss of licensure or the right to     <font color="blue">participate</font> in <font color="blue">various programs</font>, or the imposition of fines, penalties and     other sanctions</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">disclosure</font> of any <font color="blue">adverse investigation</font> or     audit results or <font color="blue">sanctions could negatively affect</font> our industry or our     reputation in <font color="blue">various markets</font> and make it more <font color="blue">difficult</font> for us to sell our     products and services</td>
    </tr>
    <tr>
      <td>Other areas subject to substantial regulation include:           •   licensing <font color="blue">requirements</font>;           •   approval of <font color="blue">policy language</font> and benefits;           •   <font color="blue">mandated benefits</font> and processes;           •   approval of entry, withdrawal or re-entry into a state or market;           •   <font color="blue">premium rates</font>; and           •   <font color="blue">periodic examinations by</font> state and <font color="blue">federal agencies</font></td>
    </tr>
    <tr>
      <td>In recent years, <font color="blue">significant</font> federal and state <font color="blue">legislation</font> affecting our     business has <font color="blue">been enacted</font></td>
    </tr>
    <tr>
      <td>State and federal <font color="blue">government</font>al <font color="blue">authorities</font> are     <font color="blue">continually</font> considering changes to laws and <font color="blue">regulations</font> applicable to us and     are currently considering <font color="blue">regulations</font> relating to:           •   health insurance access and <font color="blue">affordability</font>;           •   e-connectivity;           •   <font color="blue">disclosure</font> of provider fee schedules and other <font color="blue">data about payments</font> to     providers, sometimes called transparency;           •   <font color="blue">disclosure</font> of <font color="blue">provider quality</font> information; and           •   formation of regional/national association health plans for small     employers</td>
    </tr>
    <tr>
      <td>All of these proposals could apply to us and could result in new <font color="blue">regulations</font>     that increase the cost of our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>There can be no assurance that we will be able to continue to obtain or     maintain required <font color="blue">government</font>al approvals or licenses or that <font color="blue">legislative</font> or     <font color="blue">regulatory</font> change will not have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>Delays in obtaining or failure to obtain or maintain required approvals     could <font color="blue">adversely</font> affect entry into new markets, our revenues or the number of     our members, increase our costs or <font color="blue">adversely</font> affect our ability to <font color="blue">bring new</font>     products to <font color="blue">market as forecasted</font></td>
    </tr>
    <tr>
      <td>The level of our <font color="blue"><font color="blue">administrative expenses</font> impacts</font> our <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>While we     attempt to manage <font color="blue"><font color="blue">effective</font>ly</font> such expenses, increases in staff-related     expenses, investment in <font color="blue">new products</font>, including our <font color="blue">opportunities</font> in the     Medicare programs, greater emphasis on small group and individual health     insurance  products,  <font color="blue">acquisition</font>s,  and  <font color="blue">implementation</font> of <font color="blue">regulatory</font>     <font color="blue">requirements</font>, among others, may occur from time to time</td>
    </tr>
    <tr>
      <td>There can be no assurance that we will be able to <font color="blue">successfully</font> contain our     <font color="blue">administrative expenses</font> in line with our <font color="blue">membership</font> that may result in a     material adverse effect on our <font color="blue">financial position</font>, results of <font color="blue">operations</font> and     <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>24     ______________________________________________________________________    [46]Table of <font color="blue">Contents       </font>Any <font color="blue">failure by us</font> to manage <font color="blue">acquisition</font>s, and other <font color="blue">significant</font> <font color="blue">transactions</font>     <font color="blue">successfully</font> could harm our financial results, business and prospects</td>
    </tr>
    <tr>
      <td>As part of our business strategy, we <font color="blue">frequently</font> engage in <font color="blue">discussions with</font>     third  parties regarding possible <font color="blue">investments</font>, <font color="blue">acquisition</font>s, strategic     alliances, joint ventures, and outsourcing <font color="blue">transactions</font> and <font color="blue">often enter into</font>     <font color="blue">agreements</font> relating to such <font color="blue">transactions</font> in order to further our business     <font color="blue">objectives</font></td>
    </tr>
    <tr>
      <td>In order to pursue this strategy <font color="blue">successfully</font>, we must identify     <font color="blue">suitable candidates</font> for and <font color="blue">successfully</font> complete <font color="blue">transactions</font>, some of     which may be large and complex, and manage post-closing issues such as the     <font color="blue">integration</font> of acquired companies or employees</td>
    </tr>
    <tr>
      <td><font color="blue">Integration </font>and other risks     can be more pronounced for larger and more complicated <font color="blue">transactions</font>, or if     multiple <font color="blue">transactions</font> are <font color="blue">pursued simultaneously</font></td>
    </tr>
    <tr>
      <td>If we fail to identify and     complete <font color="blue">successfully</font> <font color="blue">transactions</font> that further our strategic <font color="blue">objectives</font>, we     may be required to <font color="blue">expend resources</font> to develop products and <font color="blue">technology</font>     <font color="blue">internally</font>, we may be at a <font color="blue">competitive disadvantage</font> or we may be <font color="blue">adversely</font>     <font color="blue">affected by negative market <font color="blue">perception</font>s</font>, any of which may have a material     adverse effect on our results of <font color="blue">operations</font>, <font color="blue">financial position</font> or cash     flows</td>
    </tr>
    <tr>
      <td>If we fail to develop and maintain satisfactory <font color="blue">relationship</font>s with the     providers of care to our members, our business could be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>We contract with physicians, hospitals and other providers to deliver health     care to our members</td>
    </tr>
    <tr>
      <td>Our <font color="blue">products encourage</font> or require our customers to use     these <font color="blue">contracted providers</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">providers may</font> share <font color="blue">medical cost</font> risk with     us or have <font color="blue">financial incentives</font> to deliver <font color="blue">quality <font color="blue">medical services</font></font> in a     cost-<font color="blue">effective</font> manner</td>
    </tr>
    <tr>
      <td>In any particular market, providers could refuse to contract with us, demand     to contract with us, demand higher payments, or take other actions that     could result in higher <font color="blue">health care</font> costs for us, less desirable products for     customers and members or <font color="blue"><font color="blue">difficult</font>y</font> meeting <font color="blue">regulatory</font> or <font color="blue">accreditation</font>     <font color="blue">requirements</font></td>
    </tr>
    <tr>
      <td>In some markets, some providers, <font color="blue">particularly</font> hospitals,     physician/hospital organizations or multi-specialty physician groups, may     have  <font color="blue">significant</font> market positions and <font color="blue">negotiating power</font></td>
    </tr>
    <tr>
      <td>In addition,     physician  or practice management companies, which aggregate physician     practices for <font color="blue">administrative efficiency</font> and marketing leverage, may compete     <font color="blue">directly with us</font></td>
    </tr>
    <tr>
      <td>If these <font color="blue">providers refuse</font> to contract with us, use their     market  position  to  negotiate  favorable  contracts or place us at a     <font color="blue">competitive disadvantage</font>, our ability to <font color="blue">market products</font> or to be profitable     in those <font color="blue">areas could</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>In some situations, we have <font color="blue">contracts with</font> individual or groups of primary     <font color="blue">care physicians</font> for an <font color="blue">actuarially</font> determined, fixed, per-member-per-month     fee  <font color="blue">under which physicians</font> are paid an amount to provide all required     <font color="blue">medical services</font> to our members</td>
    </tr>
    <tr>
      <td>This type of contract is referred to as a     “capitation” contract</td>
    </tr>
    <tr>
      <td>The inability of providers to <font color="blue">properly manage costs</font>     under these <font color="blue">capitation arrangements</font> can result in the <font color="blue">financial instability</font>     of these providers and the <font color="blue">termination</font> of their <font color="blue">relationship</font> with us</td>
    </tr>
    <tr>
      <td>In     addition, payment or other <font color="blue">disputes between</font> a <font color="blue">primary care provider</font> and     <font color="blue">specialists with whom</font> the <font color="blue">primary care provider</font> contracts can result in a     <font color="blue">disruption</font> in the provision of services to our members or a reduction in the     <font color="blue">services available</font> to our members</td>
    </tr>
    <tr>
      <td>The <font color="blue">financial instability</font> or failure of a     <font color="blue">primary care provider</font> to pay other providers for services rendered could     lead those other providers to <font color="blue">demand payment from us even though</font> we have     made our regular fixed payments to the <font color="blue">primary provider</font></td>
    </tr>
    <tr>
      <td>There can be no     assurance that providers with whom we <font color="blue">contract will properly manage</font> the     costs of services, maintain <font color="blue">financial solvency</font> or <font color="blue">avoid disputes with</font> other     providers</td>
    </tr>
    <tr>
      <td>Any of these events could have an adverse effect on the provision     of services to our members and our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If we fail to manage <font color="blue">prescription drug</font> programs <font color="blue">successfully</font>, our financial     results <font color="blue">could suffer</font></td>
    </tr>
    <tr>
      <td>In general, <font color="blue">prescription drug</font> costs have <font color="blue">been rapidly rising over</font> the past     few years</td>
    </tr>
    <tr>
      <td>These increases are due to the <font color="blue">introduction</font> of <font color="blue">new drugs costing</font>     <font color="blue">significant</font>ly more than existing drugs, direct to <font color="blue">consumer advertising by</font>     the <font color="blue">pharmaceutical industry</font> that creates <font color="blue">consumer demand</font> for particular     brand-name drugs, and <font color="blue">members seeking medications</font> to <font color="blue">address lifestyle</font>     changes</td>
    </tr>
    <tr>
      <td>In order to control <font color="blue">prescription drug</font> costs, we have                                           25     ______________________________________________________________________    [47]Table of <font color="blue">Contents       </font>implemented multi-tiered copayment benefit designs for <font color="blue"><font color="blue">prescription drug</font>s</font>,     including our four-tiered copayment benefit design, Rx4 and an Rx allowance     <font color="blue">program structured</font> to account for those drugs that treat more pervasive     <font color="blue">conditions</font> and are suggested to be more <font color="blue">effective</font> by empirical data</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> that these <font color="blue">efforts will</font> be successful in <font color="blue">controlling costs</font></td>
    </tr>
    <tr>
      <td>Failure to control these costs could have a material adverse effect on our     <font color="blue">financial position</font>, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
    <tr>
      <td>Our ability to obtain <font color="blue">funds from</font> our <font color="blue">subsidiaries</font> is restricted</td>
    </tr>
    <tr>
      <td>Because we operate as a holding company, we are <font color="blue">dependent upon dividends</font> and     administrative expense <font color="blue">reimbursements</font> from our <font color="blue">subsidiaries</font> to fund the     <font color="blue">obligations</font> of Humana Inc, our <font color="blue">parent company</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">subsidiaries</font> generally     are <font color="blue">regulated by</font> states’ <font color="blue">Departments </font>of Insurance</td>
    </tr>
    <tr>
      <td>We are also required by     law to maintain <font color="blue">specific prescribed minimum amounts</font> of capital in these     <font color="blue">subsidiaries</font></td>
    </tr>
    <tr>
      <td>The levels of <font color="blue">capitalization</font> required <font color="blue">depend primarily upon</font>     the volume of <font color="blue">premium generated</font></td>
    </tr>
    <tr>
      <td>A <font color="blue">significant</font> increase in <font color="blue">premium volume</font>     will require <font color="blue">additional</font> <font color="blue">capitalization</font> from our <font color="blue">parent company</font></td>
    </tr>
    <tr>
      <td>To fund our     expanding business <font color="blue">opportunities</font>, including the enhanced Medicare business,     we anticipate <font color="blue">additional</font> required capital ranging from dlra450 million to dlra650     million in 2006</td>
    </tr>
    <tr>
      <td>In most states, we are required to <font color="blue">seek prior approval by</font>     these state <font color="blue">regulatory</font> <font color="blue">authorities</font> before we <font color="blue">transfer money</font> or <font color="blue">pay dividends</font>     from these <font color="blue">subsidiaries</font> that <font color="blue">exceed specified amounts</font>, or, in some states,     any  amount</td>
    </tr>
    <tr>
      <td>In addition, we <font color="blue">normally notify</font> the state <font color="blue">Departments </font>of     Insurance prior to making payments that do not require approval</td>
    </tr>
    <tr>
      <td>In the     event  that  we  are  unable to provide sufficient capital to fund the     <font color="blue">obligations</font> of Humana Inc, our <font color="blue">operations</font> or <font color="blue">financial position</font> may be     <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>Ratings are an important factor in our <font color="blue">competitive position</font></td>
    </tr>
    <tr>
      <td>Claims <font color="blue">paying ability</font>, <font color="blue">financial strength</font>, and <font color="blue">debt ratings by</font> recognized     <font color="blue">rating organizations</font> are an <font color="blue">increasingly important</font> factor in <font color="blue">establishing</font>     the <font color="blue">competitive position</font> of <font color="blue">insurance companies</font></td>
    </tr>
    <tr>
      <td>Ratings information is     <font color="blue">broadly disseminated</font> and <font color="blue">generally used throughout</font> the industry</td>
    </tr>
    <tr>
      <td>We believe     our claims <font color="blue">paying ability</font> and <font color="blue"><font color="blue">financial strength</font> ratings</font> are an important     factor in marketing our products to certain of our customers</td>
    </tr>
    <tr>
      <td>Our debt     <font color="blue">ratings impact both</font> the cost and <font color="blue">availability</font> of <font color="blue">future borrowings</font></td>
    </tr>
    <tr>
      <td>Each of     the rating agencies reviews its ratings <font color="blue">periodically</font> and there can be no     assurance that current ratings will be maintained in the future</td>
    </tr>
    <tr>
      <td>Our ratings     reflect each rating agency’s opinion of our <font color="blue">financial strength</font>, operating     performance, and ability to meet our debt <font color="blue">obligations</font> or <font color="blue">obligations</font> to     policyholders, but are not <font color="blue">evaluations directed toward</font> the protection of     investors  in  our <font color="blue">common stock</font> and should not be <font color="blue">relied upon as such</font></td>
    </tr>
    <tr>
      <td><font color="blue">Downgrades </font>in our ratings, should they occur, may <font color="blue">adversely</font> affect our     business, <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Increased </font><font color="blue">litigation</font> and <font color="blue">negative publicity could increase</font> our cost of doing     business</td>
    </tr>
    <tr>
      <td>The <font color="blue">health benefits industry continues</font> to receive <font color="blue">significant</font> negative     <font color="blue">publicity reflecting</font> the <font color="blue">public <font color="blue">perception</font></font> of the industry</td>
    </tr>
    <tr>
      <td>This publicity     and <font color="blue">perception</font> have been accompanied by increased <font color="blue">litigation</font>, including some     large jury awards, <font color="blue">legislative</font> activity, regulation and <font color="blue">government</font>al review     of <font color="blue">industry practices</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">factors may</font> <font color="blue">adversely</font> affect our ability to     market our products or services, may require us to change our products or     services, may increase the <font color="blue">regulatory</font> burdens under which we operate and may     require us to pay large judgments or fines</td>
    </tr>
    <tr>
      <td>Any <font color="blue">combination</font> of these factors     <font color="blue">could further increase</font> our cost of doing business and <font color="blue">adversely</font> affect our     <font color="blue">financial position</font>, results of <font color="blue">operations</font> and <font color="blue">cash flows</font></td>
    </tr>
  </tbody>
</table>